Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Copper in the ICU may ward off health care-acquired infections
(April 9, 2013 - Insidermedicine) From South Carolina – A ...
(April 9, 2013 - Insidermedicine) From South Carolina – A new report published in Infection Control and Hospital Epidemiology finds that copper surfaces in the ICU can greatly reduce health care-acquired infections. Researchers randomly assigned ICU patients at three hospitals to receive traditional care or to be placed in a room with copper-based bed rails, tables, IV poles and call buttons. Results showed that patients in the copper surfaced room were much less likely to develop methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) than those in traditional hospital rooms.
-
HD
Gene variant nearly doubles risk of Alzheimer's disease in African Americans
(Aril 9, 2013 - Insidermedicine) From New York – A ...
(Aril 9, 2013 - Insidermedicine) From New York – A common gene mutation nearly doubles risk of Alzheimer’s disease in African Americans, according to a report published in JAMA. Researchers studied nearly 6,000 African Americans, 2,000 of whom were diagnosed with probable Alzheimer’s disease and 4,000 who were cognitively normal. Genome analysis revealed a variant of the ABCA7 gene, a minor variation in whites, that raised risk of Alzheimer’s nearly twofold in African Americans.
-
HD
Elevated estrogen levels while pregnant may raise risk of breast cancer in daughter
(April 9, 2013 - Insidermedicine) From Washington – According to ...
(April 9, 2013 - Insidermedicine) From Washington – According to a report presented at the AACR’s annual meeting, elevated estrogen levels during pregnancy may raise risk of breast cancer in the child. Researchers compared DNA methylation profiles of daughters exposed to high estrogen levels in the womb to data on breast cancer patients taken from the Cancer Genome Atlas. They found that the tumor suppressing gene, BRCA1, was silenced by DNA methylation in the daughters of women with excess estrogen levels during pregnancy. These results suggest that researchers may be able to identify which women are at higher risk of developing breast cancer.
-
HD
Only half of women at risk of BRCA mutation are recommended for genetic testing
(April 8, 2013 - Insidermedicine) From Pennsylvania - Only half ...
(April 8, 2013 - Insidermedicine) From Pennsylvania - Only half of all breast patients at risk of having a BRCA mutation are sent for genetic testing, according to a report presented at the AACR's annual meeting. Researchers surveyed over 2,200 breast cancer patients aged 18-64. Researchers found that, while women at low risk of the mutation were properly advised, only 53% of those who were at high risk were urged to get genetic testing done.
-
HD
IUDs are safe for teenagers
(April 8, 2013 - Insidermedicine) From Texas - A new ...
(April 8, 2013 - Insidermedicine) From Texas - A new report published in Obstetrics & Gynecology finds that IUDs are as safe for teenagers as they are for adults. Researchers studied the insurance claims from nearly 90,000 IUD users aged 15-44, reviewing any complications, failures, or discontinuation of the devices. They found that serious complications from the IUD only occurred in less than 1% of the women, regardless of their age. As well, early discontinuation of the devices was similar for older and younger women.
-
HD
Alcohol consumption does not appear to affect breast cancer survival
(April 8, 2013 - Insidermedicine) From Seattle - Alcohol may ...
(April 8, 2013 - Insidermedicine) From Seattle - Alcohol may not impact breast cancer survival, according to a report published in the Journal of Clinical Oncology. Researchers studied nearly 23,000 breast cancer patients taking part in a long term study. The study began in 1988 and 5,000 of the participants were followed until 2001. These women were surveyed regarding their alcohol consumption after being diagnosed with breast cancer. Results showed that the amount and type of alcohol that a woman drank after her diagnosis did not increase her risk of dying from the disease. Researchers also found that women who were moderate drinkers (3-6 drinks a week) were at 15% lower risk of dying from heart disease than women who did not drink at all.
-
HD
HIV self-testing may be key to stopping epidemic
(April 5, 2013 - Insidermedicine) From Montreal - Self-testing for ...
(April 5, 2013 - Insidermedicine) From Montreal - Self-testing for HIV may be key to controlling the virus's epidemic, according to a report published in PLoS Medicine. Researchers conducted a meta-analysis, covering 21 studies worldwide that examined both supervised and unsupervised oral HIV self-testing. Results showed that both types of testing were highly accepted. In fact, people actually preferred self-testing to facility-based testing, and the oral test to blood-based tests
-
HD
Most diabetes trials focus on treatment rather than prevention
(April 5, 2013 - Insidermedicine) From North Carolina – A ...
(April 5, 2013 - Insidermedicine) From North Carolina – A majority of diabetes trials focus on treatment instead of prevention, according to a report published in Diabetologia. Researchers reviewed over 2,400 interventional trials, most of which were small to medium sized, typically enrolling under 500 participants. They found that 75% of the trials were focused on drug therapy, while only 10% focused on prevention with behavioural or lifestyle changes. Only 4% of the trials were targeted towards people under the age of 18, and less than 1% targeted individuals over the age of 65.
-
HD
Chronic pain common among stroke survivors
(April 4, 2013 - Insidermedicine) From Hamilton - Chronic pain ...
(April 4, 2013 - Insidermedicine) From Hamilton - Chronic pain is common among stroke survivors, according to a report published in Stroke. Researchers studied over 15,000 patients who had survived a mild to moderate stroke. Participants were followed for an average of 30 months. Results showed that over 1,600, or 10.6%, of the patients reported suffering chronic pain after their stroke.
-
HD
Walking as good as running for reducing risk of heart-related problems
(April 4, 2013 - Insidermedicine) From California - Walking is ...
(April 4, 2013 - Insidermedicine) From California - Walking is as good for the heart as running, according to a report published in Arteriosclerosis, Thrombosis and Vascular Biology. Researchers compared over 33,000 runners taking part in the National Runners' Health Study to over 15,000 walkers taking part in the National Walkers' Health Study. Participants reported their activity levels and researchers assessed their energy expenditure by distance traveled. Results showed that running and brisk walking had similar reductions in risk of hypertension, diabetes, hypercholesterolemia, and heart disease.
